News: DLBS

1 August 2022

Dexa Award Science Scholarship 2022 Stimulates Innovation to Build Health Independence

The Indonesian government continues to encourage the resilience and independence of the healthcare industry, as imports dominate 90% of its domestic pharmaceutical raw materials and health spending. In addition, 88% of medical device transactions through electronic catalogs (e-catalogs) are imported products. Meanwhile, research and development funds are only about 0.2%…
8 December 2021

Dexa Group Appreciated by Government for Contribution to Improving National Industry Competitiveness through OMAI Research and Innovation

Taking an active role in increasing the competitiveness of the national industry through research and sustainable technological innovation in the pharmaceutical sector, Dexa Laboratories of Biomolecular Sciences (DLBS) received the Rintisan Teknologi Industri 2021 award from the Ministry of Industry of the Republic of Indonesia. The award was handed over…
26 March 2021

Deputy Minister of Health: OMAI Must Be in the JKN E-Catalog Listing

The support for Indonesia Indigenous Modern Medicine (OMAI) to be included in the National Health Insurance (JKN) program continues to be supported. This support surfaced in the 2nd Webinar Series held by the University of Indonesia Board of Trustees (MWA UI) with the theme "Indonesian Health Resilience and Independence" on…
23 March 2021

PIT PDHMI: Indonesia Indigenous Modern Medicine Proven Preclinically and Clinically for Disease Treatment

Indonesia Indigenous Modern Medicine (OMAI) has been proven preclinically and clinically for the treatment or therapy of disease. At the 2021 Indonesian Medical Herbal Medicine Association Annual Scientific Meeting (PIT PDHMI), scientists and also health practitioners agreed that OMAI could be used for the treatment of patients. "The doctors they…
16 February 2021

Dr. Raymond Tjandrawinata: Boost Immunity with Immunomodulators Original Indonesian Modern Medicines

Farid Nila Moeloek (FNM) Society held a webinar entitled "Use of Herbs to Increase Immunity in the COVID-19 Pandemic". The discussion, which was attended by experts in the health sector, concluded that it was time for Indonesian Original Modern Medicine (OMAI) to be included in the medical education curriculum. "How…
25 May 2020

DLBS Executive Director Listed as SINTA 2020 Best Researcher

Executive Director of Dexa Laboratories of Biomolecular Sciences (DLBS), Dr. Raymond R. Tjandrawinata has been named the Best Researcher in the Science and Technology Index (SINTA) 2020 by scoring very high cumulative Google Scholar H-index. The total number of researchers who work as lecturers and are registered at SINTA is…
16 December 2019

Dexa Group Awarded Rintisan Teknologi Industri Award by Ministry of Industry Indonesia

Dexa Group received two prestigious awards from the Ministry of Industry Indonesia, which are the Green Industry Award 2019 through PT Ferron Par Pharmaceuticals and the Technology Pioneer Award 2019 through PT Dexa Medica. The awards were given for the company’s commitment to increasing industry competitiveness around research development and…
4 December 2019

Government Appreciates Dexa Group Research and Development

The Ministry of Research and Technology of the Republic of Indonesia appreciates Dexa Group through PT Dexa Medica as an industry that contributes to research and development activities to produce pharmaceutical products that have competitive advantage and innovation. Minister of Research and Technology (Menristek) / Head of the Research and…
14 December 2018

Kemenristekdikti Presented Dexa Medica the Innovative Industrial Research and Development Institution Award

Dexa Medica received a prestigious award from the Ministry of Research and Technology and Higher Education (Kemenristekdikti) at the Innovative Industrial Research and Development Institution (IIRDI) Award 2018 for its research and development strategy in producing innovative and quality pharmaceutical products, winning over 40 other institutions in the industry. The…
4 July 2018

Dexa Medica’s Director of Innovation and Scientific Development Wins SINTA Awards 2018

Director of Innovation and Scientific Development of PT Dexa Medica, Raymond R. Tjandrawinata, Ph.D., M.S., MBA has taken home the SINTA (Science and Technology Index) Awards 2018 in the Author Category of the Scientific Publication with the highest SINTA Score for Private University Category on Wednesday, 4 July 2018. SINTA…